- Home
- LEGT vs LRMR Comparison
LEGT vs LRMR Comparison
Compare LEGT & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.76
Company Overview
Basic Information| Metric | LEGT | LRMR |
|---|---|---|
| Founded | 2023 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 278.6M | 332.1M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | LEGT | LRMR |
|---|---|---|
| Price | $10.82 | $3.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $16.71 |
| AVG Volume (30 Days) | 47.2K | ★ 1.4M |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $32.82 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.29 | $1.61 |
| 52 Week High | $11.25 | $6.48 |
Technical Indicators
Market Signals| Indicator | LEGT | LRMR |
|---|---|---|
| Relative Strength Index (RSI) | 48.65 | 51.64 |
| Support Level | $10.79 | $3.12 |
| Resistance Level | $10.86 | $4.15 |
| Average True Range (ATR) | 0.03 | 0.25 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 63.64 | 67.48 |
Price Performance
Historical Comparison LEGT
LRMR
About LEGT Legato Merger Corp. III
Legato Merger Corp III is a blank check company.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.